GSE80098 GSE80366 progesterone 0 v 8 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE80098_GSE80366_progesterone_0_v_8_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE80098_GSE80366_progesterone_0_v_8_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE80098_GSE80366_progesterone_0_v_8_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE80098_GSE80366_progesterone_0_v_8_human_up.

Results found

Linked to

 

Label

Description

 

Gene

acetylserotonin O-methyltransferase like

Gene

family with sequence similarity 106 member A

Gene

MIR4435-2 host gene

Gene

growth arrest specific 5

Gene

small nucleolar RNA host gene 29

Gene

MSL complex subunit 3B

Gene

H2A clustered histone 11

Gene

tripartite motif containing 16 like (pseudogene)

Gene

cytoskeleton regulator RNA

Gene

PAX8 antisense RNA 1

  • Gene

    acetylserotonin O-methyltransferase like


  • Gene

    family with sequence similarity 106 member A



  • Gene

    growth arrest specific 5


  • Gene

    small nucleolar RNA host gene 29


  • Gene

    MSL complex subunit 3B


  • Gene

    H2A clustered histone 11


  • Gene

    tripartite motif containing 16 like (pseudogene)


  • Gene

    cytoskeleton regulator RNA


  • Gene

    PAX8 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.